The impact of current antiemetic practices on patient outcomes: A prospective study on high-risk patients

Paul F. White, Jerome F. O'Hara, Charles R. Roberson, Ronald H. Wender, Keith A Candiotti

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

BACKGROUND: In this prospective, multicenter, observational study, we evaluated the incidence and time course of postoperative nausea and vomiting (PONV), assessed prophylactic and rescue antiemetic use in high-risk patients, and determined population-based effectiveness of antiemetics, including the impact of American Society of Anesthesiologists (ASA) and American Society of Perianesthesia Nurses (ASPAN) guideline compliance. METHODS: Eligible patients undergoing elective laparoscopic or major plastic surgery possessed two or more of the following Apfel PONV risk factors: female gender, history of PONV or motion sickness, and nonsmoking status. Antiemetic use, emetic episodes, severity of nausea, and functional interference due to PONV were documented during the first 72 h after surgery. Complete response (CR) was defined as no emesis or rescue medication use, and complete control was defined as CR and no moderate-severe nausea. The effect of compliance (versus noncompliance) with ASA and ASPAN guidelines on PONV outcomes was also analyzed. RESULTS: The proportion of patients experiencing postoperative emesis ranged from 18% to 40% depending on the number of antiemetics administered. The rate of rescue medication (45%) was similar to the reported incidences of moderate-to-severe nausea (47%) and functional interference due to emetic symptoms (44%). The administration of three or more antiemetics produced better patient outcomes overall compared to <1 prophylactic antiemetic. CR rates were <70% despite adherence to current organizational PONV management guidelines (ASA: 69%; ASPAN: 63%). The complete control rates were 10% lower than CR rates over the 3 day study period. CONCLUSIONS: Administration of three or more prophylactic antiemetics had the most positive impact on emetic outcomes over 72 hrs in patients at risk of developing PONV. Although compliance with organizational PONV management guidelines improved patient outcomes, postoperative emetic symptoms and interference with patient functioning still occurred in more than 30% of these high-risk patients.

Original languageEnglish
Pages (from-to)452-458
Number of pages7
JournalAnesthesia and Analgesia
Volume107
Issue number2
DOIs
StatePublished - Aug 1 2008

Fingerprint

Postoperative Nausea and Vomiting
Antiemetics
Prospective Studies
Emetics
Guidelines
Nausea
Nurses
Compliance
Motion Sickness
Incidence
Plastic Surgery
Multicenter Studies
Vomiting
Observational Studies

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

The impact of current antiemetic practices on patient outcomes : A prospective study on high-risk patients. / White, Paul F.; O'Hara, Jerome F.; Roberson, Charles R.; Wender, Ronald H.; Candiotti, Keith A.

In: Anesthesia and Analgesia, Vol. 107, No. 2, 01.08.2008, p. 452-458.

Research output: Contribution to journalArticle

White, Paul F. ; O'Hara, Jerome F. ; Roberson, Charles R. ; Wender, Ronald H. ; Candiotti, Keith A. / The impact of current antiemetic practices on patient outcomes : A prospective study on high-risk patients. In: Anesthesia and Analgesia. 2008 ; Vol. 107, No. 2. pp. 452-458.
@article{6edeed9b65444e7a8afa3142ac66bade,
title = "The impact of current antiemetic practices on patient outcomes: A prospective study on high-risk patients",
abstract = "BACKGROUND: In this prospective, multicenter, observational study, we evaluated the incidence and time course of postoperative nausea and vomiting (PONV), assessed prophylactic and rescue antiemetic use in high-risk patients, and determined population-based effectiveness of antiemetics, including the impact of American Society of Anesthesiologists (ASA) and American Society of Perianesthesia Nurses (ASPAN) guideline compliance. METHODS: Eligible patients undergoing elective laparoscopic or major plastic surgery possessed two or more of the following Apfel PONV risk factors: female gender, history of PONV or motion sickness, and nonsmoking status. Antiemetic use, emetic episodes, severity of nausea, and functional interference due to PONV were documented during the first 72 h after surgery. Complete response (CR) was defined as no emesis or rescue medication use, and complete control was defined as CR and no moderate-severe nausea. The effect of compliance (versus noncompliance) with ASA and ASPAN guidelines on PONV outcomes was also analyzed. RESULTS: The proportion of patients experiencing postoperative emesis ranged from 18{\%} to 40{\%} depending on the number of antiemetics administered. The rate of rescue medication (45{\%}) was similar to the reported incidences of moderate-to-severe nausea (47{\%}) and functional interference due to emetic symptoms (44{\%}). The administration of three or more antiemetics produced better patient outcomes overall compared to <1 prophylactic antiemetic. CR rates were <70{\%} despite adherence to current organizational PONV management guidelines (ASA: 69{\%}; ASPAN: 63{\%}). The complete control rates were 10{\%} lower than CR rates over the 3 day study period. CONCLUSIONS: Administration of three or more prophylactic antiemetics had the most positive impact on emetic outcomes over 72 hrs in patients at risk of developing PONV. Although compliance with organizational PONV management guidelines improved patient outcomes, postoperative emetic symptoms and interference with patient functioning still occurred in more than 30{\%} of these high-risk patients.",
author = "White, {Paul F.} and O'Hara, {Jerome F.} and Roberson, {Charles R.} and Wender, {Ronald H.} and Candiotti, {Keith A}",
year = "2008",
month = "8",
day = "1",
doi = "10.1213/ane.0b013e31817b842c",
language = "English",
volume = "107",
pages = "452--458",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The impact of current antiemetic practices on patient outcomes

T2 - A prospective study on high-risk patients

AU - White, Paul F.

AU - O'Hara, Jerome F.

AU - Roberson, Charles R.

AU - Wender, Ronald H.

AU - Candiotti, Keith A

PY - 2008/8/1

Y1 - 2008/8/1

N2 - BACKGROUND: In this prospective, multicenter, observational study, we evaluated the incidence and time course of postoperative nausea and vomiting (PONV), assessed prophylactic and rescue antiemetic use in high-risk patients, and determined population-based effectiveness of antiemetics, including the impact of American Society of Anesthesiologists (ASA) and American Society of Perianesthesia Nurses (ASPAN) guideline compliance. METHODS: Eligible patients undergoing elective laparoscopic or major plastic surgery possessed two or more of the following Apfel PONV risk factors: female gender, history of PONV or motion sickness, and nonsmoking status. Antiemetic use, emetic episodes, severity of nausea, and functional interference due to PONV were documented during the first 72 h after surgery. Complete response (CR) was defined as no emesis or rescue medication use, and complete control was defined as CR and no moderate-severe nausea. The effect of compliance (versus noncompliance) with ASA and ASPAN guidelines on PONV outcomes was also analyzed. RESULTS: The proportion of patients experiencing postoperative emesis ranged from 18% to 40% depending on the number of antiemetics administered. The rate of rescue medication (45%) was similar to the reported incidences of moderate-to-severe nausea (47%) and functional interference due to emetic symptoms (44%). The administration of three or more antiemetics produced better patient outcomes overall compared to <1 prophylactic antiemetic. CR rates were <70% despite adherence to current organizational PONV management guidelines (ASA: 69%; ASPAN: 63%). The complete control rates were 10% lower than CR rates over the 3 day study period. CONCLUSIONS: Administration of three or more prophylactic antiemetics had the most positive impact on emetic outcomes over 72 hrs in patients at risk of developing PONV. Although compliance with organizational PONV management guidelines improved patient outcomes, postoperative emetic symptoms and interference with patient functioning still occurred in more than 30% of these high-risk patients.

AB - BACKGROUND: In this prospective, multicenter, observational study, we evaluated the incidence and time course of postoperative nausea and vomiting (PONV), assessed prophylactic and rescue antiemetic use in high-risk patients, and determined population-based effectiveness of antiemetics, including the impact of American Society of Anesthesiologists (ASA) and American Society of Perianesthesia Nurses (ASPAN) guideline compliance. METHODS: Eligible patients undergoing elective laparoscopic or major plastic surgery possessed two or more of the following Apfel PONV risk factors: female gender, history of PONV or motion sickness, and nonsmoking status. Antiemetic use, emetic episodes, severity of nausea, and functional interference due to PONV were documented during the first 72 h after surgery. Complete response (CR) was defined as no emesis or rescue medication use, and complete control was defined as CR and no moderate-severe nausea. The effect of compliance (versus noncompliance) with ASA and ASPAN guidelines on PONV outcomes was also analyzed. RESULTS: The proportion of patients experiencing postoperative emesis ranged from 18% to 40% depending on the number of antiemetics administered. The rate of rescue medication (45%) was similar to the reported incidences of moderate-to-severe nausea (47%) and functional interference due to emetic symptoms (44%). The administration of three or more antiemetics produced better patient outcomes overall compared to <1 prophylactic antiemetic. CR rates were <70% despite adherence to current organizational PONV management guidelines (ASA: 69%; ASPAN: 63%). The complete control rates were 10% lower than CR rates over the 3 day study period. CONCLUSIONS: Administration of three or more prophylactic antiemetics had the most positive impact on emetic outcomes over 72 hrs in patients at risk of developing PONV. Although compliance with organizational PONV management guidelines improved patient outcomes, postoperative emetic symptoms and interference with patient functioning still occurred in more than 30% of these high-risk patients.

UR - http://www.scopus.com/inward/record.url?scp=49949096487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=49949096487&partnerID=8YFLogxK

U2 - 10.1213/ane.0b013e31817b842c

DO - 10.1213/ane.0b013e31817b842c

M3 - Article

C2 - 18633023

AN - SCOPUS:49949096487

VL - 107

SP - 452

EP - 458

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -